Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Sale-Or-Purchase-of-Stock" stands at -5.88 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 12/31/2023.
Johnson & Johnson's third quarter result of -1.90 Billion USD for the item "Sale Or Purchase of Stock" represents a decrease of -21.15 percent compared to it's second quarter result.
Also, Johnson & Johnson's third quarter result of -1.90 Billion USD for the item "Sale Or Purchase of Stock" represents a decrease of -252.88 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Johnson & Johnson's third quarter result of -5.88 Billion USD for the item "Sale Or Purchase of Stock" represents a decrease of -30.17 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -3.52 Billion United States Dollars compared to the value the year prior.
The 1 year change is -3.52 Billion United States Dollars.
The 3 year change is -0.17 Billion United States Dollars.
The 5 year change is -2.56 Billion United States Dollars.
The 10 year change is 0.256 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Sale Or Purchase of Stock | 905,699,262,464.00 |
![]() | AbbVie Inc - Sale Or Purchase of Stock | 399,570,305,024.00 |
![]() | Roche Holding AG - Sale Or Purchase of Stock | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Sale Or Purchase of Stock | 280,205,508,085.11 |
![]() | Novartis AG - Sale Or Purchase of Stock | 255,096,620,580.91 |